Renal Papillary Adenoma

Slide 1 · Renal Papillary Adenoma

Morphology · differential diagnosis · classification boundaries

Renal epithelial neoplasms

An integrated pathology lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define papillary adenoma within the spectrum of renal epithelial tumors.

Recognize its gross and microscopic features.

Apply the low-grade morphology and 15-mm size boundary correctly.

Differentiate mimics and explain limitations of biopsy, IHC, and genetics.

Interpret small renal lesions using clinical and sampling context.

Slide 3 · Renal tumors: Position of papillary adenoma

Renal neoplasms

Benign / low-risk lesions

Malignant neoplasms

Example: Papillary adenoma

Small, bland tubular / papillary lesion in the cortex.

Example: Papillary RCC

Morphologic overlap; Classification requires complete context.

Core distinction

“Papillary” describes architecture; It does not independently define biologic behavior.

Slide 4 · Definition: A small renal tubular epithelial neoplasm

Papillary adenoma is a discrete proliferation of renal tubular-type epithelium.

Architecture is papillary, tubular, or tubulopapillary.

The cells show bland, low-grade cytology.

It is categorized separately from papillary renal cell carcinoma.

Do not infer

“Adenoma” requires size and morphologic context—not a single bland field.

Slide 5 · Why papillary adenoma is a useful diagnostic concept

Observation

Practical consequence

Common microscopic incidental finding

Often not a clinically evident mass

Can resemble a small papillary RCC

Frequently discovered during evaluation of another process

Separates low-risk lesions from malignancy

Avoids overtreatment from isolated cytologic resemblance

Requires careful size and grade assessment

Encourages whole-lesion evaluation

Slide 6 · Autopsy prevalence is substantial

7%–22%

Autopsy frequency reported

Interpretation

These tumors are frequent occult pathologic findings; Do not equate an autopsy percentage with clinical cancer incidence.

Slide 7 · Prevalence does not mean clinical aggressiveness

Frequent incidental lesion

No symptoms in most tiny lesions

Autopsy detection

Avoid conflation

An incidental benign epithelial nodule is not equivalent to a diagnosed renal carcinoma.

Slide 8 · Anatomic origin: Renal tubular-type epithelium

CORTEX

MEDULLA

Small cortical nodule

Schematic section

Anatomic context

Papillary adenomas arise in the renal parenchyma, usually as cortical nodules; They do not originate in urothelium lining the renal pelvis.

Slide 9 · Cortical location separates it from pelvic tumors

Papillary adenoma

Pelvic urothelial lesion

Cortical parenchyma

Renal epithelial tumor

Papillary / tubular microarchitecture

Renal pelvis or calyces

Urothelial lining / urothelial tumor

Different histogenesis and morphologic differential

Slide 10 · Gross size: Small, typically below 1.5 cm

0

15 mm / 1.5 cm

Teaching threshold in modern classification

Important

This cutoff is operational. Size does not override cytologically aggressive features.

Slide 11 · Gross distribution: Circumscribed cortical nodules

CORTEX

MEDULLA

Small cortical nodule

Schematic section

Robbins description

Discrete, well-circumscribed, pale yellow-gray nodules located in the renal cortex.

Pathology implication

Small cortical foci may be detected only by careful sampling or on non-tumor renal tissue sections.

Slide 12 · Gross appearance cannot confirm histologic subtype

Macroscopic clue

Why it is insufficient

Small size

Sharp circumscription

Pale yellow-gray appearance

Not exclusive to papillary adenoma

Other renal tumors may look circumscribed

Microscopic features and full context are required

Slide 13 · A clinically detected renal mass is a different setting

Small incidental focus

Histologic classification

Correlate size + cytology

Clinical boundary

Do not label a radiologic renal mass “papillary adenoma” on size alone.

Slide 14 · Microscopic architecture is papillary and tubular

Papillary

Branching fronds form a complex papillary configuration.

Tubular

Tubule-like channels may constitute part of the lesion.

Solid nests

Areas of compact epithelial growth may also occur.

Schematic

Slide 15 · Papillae are epithelial fronds around a central core

Uniform epithelial lining

Fibrovascular core

Schematic

Slide 16 · Branching papillae explain the lesion name

Branching fronds create a complex papillary contour

Schematic

Slide 17 · Tubules can coexist with papillae

Tubulopapillary architecture can vary within one small lesion

Schematic

Slide 18 · Solid cell nests are compatible with adenoma

Interpretation

A compact nest-like field is not sufficient to call a neoplasm malignant. Architecture must be integrated with the overall low-grade lesion.

Schematic

Slide 19 · Epithelial cells are cuboidal to polygonal

Expected cell form

Low, uniform epithelial cells line papillae and tubules; Cells are not overtly pleomorphic.

Schematic

Slide 20 · Nuclear appearance: Small and uniform

Regular, small central nuclei; No significant atypia

Schematic

Slide 21 · Cytoplasmic appearance: Scant relative to nucleus

Robbins

Cells have scant cytoplasm with bland central nuclei.

Diagnostic relevance

Cytoplasmic volume alone is nonspecific; Uniform nuclei and lesion-level classification remain more important.

Schematic

Slide 22 · Absent atypia is integral, not incidental

Compatible with low grade

Features to investigate

Small, similar nuclei

Smooth contours

No marked pleomorphism

No overtly malignant cytology

Striking nucleoli

Marked pleomorphism

Necrosis or aggressive architecture

Concern for carcinoma → reassess diagnosis

Slide 23 · Low-power to high-power assessment

Low-power contour

Papillary / tubular pattern

Nuclear details

Size + sampling

Sequence

Architecture and nuclear findings must be reviewed across the full lesion.

Slide 24 · A summary of the core morphologic pattern

Domain

Typical finding

Diagnostic role

Site

Renal cortex

Supports location

Gross

Pale, small, circumscribed

Not independently diagnostic

Architecture

Papillary / tubular / nests

Establishes pattern

Nuclei

Small, uniform, bland

Low-grade prerequisite

Size

Typically ≤15 mm

Operational boundary

Slide 25 · Papillary adenoma and papillary RCC share features

Papillary adenoma

Papillary RCC

Papillary / tubulopapillary growth

Bland small cells in low-grade lesions

Some overlapping immunophenotypic findings

Trisomies of chromosomes 7 and 17

Papillary / tubulopapillary growth

Low-grade variants can look identical

Shared marker expression

Shared cytogenetic abnormalities

Slide 26 · Cytogenetic overlap: Chromosomes 7 and 17

Trisomy 7

Trisomy 17

Seen in papillary adenoma and papillary RCC

Interpretation

A shared genetic change supports biological relatedness—not a diagnosis of carcinoma.

Slide 27 · Shared genetics do not establish malignant behavior

Molecular overlap

Possible biologic continuum

Cannot prove progression

Boundary

An adenoma–carcinoma sequence has been proposed; An individual adenoma cannot be assumed to progress.

Slide 28 · Papillary RCC can show MET pathway abnormalities

Small adenoma

Related carcinoma context

Papillary adenoma

Documented overlap: +7, +17

Do not assign MET mutation without testing

Hereditary papillary RCC

Gain-of-function MET mutations documented

Some sporadic papillary RCCs also harbor MET changes

Slide 29 · Immunohistochemistry cannot substitute for size

Typical immunoprofile

Papillary lineage supported

Adenoma vs RCC unresolved

Central limit

No routine single stain reliably separates papillary adenoma from low-grade papillary RCC.

Slide 30 · CK7 and AMACR: Supportive, not decisive

Marker

Usual pattern

Correct interpretation

CK7

Often positive

Compatible with papillary differentiation

AMACR

Often positive

Compatible with papillary differentiation

Together

May support papillary lineage

Do not classify behavior alone

Caution

Stain patterns must be interpreted with morphology, lesion size, and material limitations.

Slide 31 · Why a numerical threshold is used

Bland papillary adenoma and low-grade papillary RCC can be microscopically identical.

A size boundary operationalizes a practical classification.

The threshold does not imply an abrupt biological transformation at 15 mm.

Atypical or invasive features remain red flags regardless of size.

Slide 32 · The 15-mm boundary is a diagnostic convention

≤15 mm + low-grade features

>15 mm

Potential papillary adenoma

Classify as papillary RCC when appropriate

Not a one-variable rule

A small tumor with marked atypia must not be called an adenoma.

Slide 33 · How the historical definition changed

Earlier WHO: 5 mm

WHO 2016: 15 mm

Current clinical teaching: 15 mm

Context

Always specify the classification edition when discussing a size threshold.

Slide 34 · A 12-mm bland tumor: Possible adenoma

Observed features

Cortical nodule, 12 mm, papillary / tubular, uniform low-grade nuclei.

Reasoning

Size is within the operational boundary and morphology is compatible—provided the entire lesion is assessed.

Caveat

The term should not rest on a limited core biopsy with uncertain true size or unassessed features.

Slide 35 · An 18-mm low-grade papillary lesion: Not adenoma

Observed features

Well-circumscribed 18-mm papillary renal epithelial tumor; Nuclei remain bland.

Diagnostic logic

Histologic blandness does not override the size-based definition: Evaluate/classify as papillary RCC.

Pitfall

Do not downgrade a >15-mm papillary RCC to adenoma because of an innocuous appearance.

Slide 36 · A 9-mm lesion with marked atypia is not “safe”

Observed features

Small papillary nodule with nuclear pleomorphism and conspicuous nucleoli.

Diagnostic logic

Marked cytologic atypia contradicts the bland adenoma profile even though size is below 15 mm.

Rule

Assess high-grade features first; The cutoff applies to appropriately low-grade lesions.

Slide 37 · Whole-lesion size matters more than slide dimensions

Record the largest pathologic tumor dimension when available.

Do not estimate an entire mass from one histologic field or a small core.

If the lesion is incompletely represented, disclose the limitation.

Correlate the pathologic specimen with imaging and operative information.

Slide 38 · Core biopsy may not establish adenoma

Small tissue fragment

Bland papillary tumor

Need lesion size / whole-mass assessment

Preferred uncertainty

Report a low-grade papillary renal epithelial neoplasm when categorical classification is unsupported by sampling.

Slide 39 · A practical decision sequence for small papillary lesions

Confirm papillary / tubulopapillary phenotype

Assess nuclear grade and aggressive features

Review maximal size and sampling adequacy

Choose terminology consistent with evidence

Slide 40 · Growth pattern and nuclei have different roles

Question

Evidence

Consequence

What is the lineage?

Architecture ± CK7 / AMACR

Papillary epithelial lesion

Is it bland?

Small regular nuclei; No atypia

Low-grade morphology

Is it an adenoma?

Complete size ≤15 mm; No warning features

Potential adenoma diagnosis

Is sampling adequate?

Whole lesion / appropriate material

Confidence or qualified report

Slide 41 · Papillary RCC is the most important differential

Papillary adenoma

Papillary RCC

Very small / ≤15-mm category

Bland low-grade cells

Unencapsulated focus may occur

Cannot be separated by IHC alone

Often exceeds 15 mm

Can show identical low-grade histology

May be multifocal and larger

Gross size and malignant features decide

Slide 42 · Papillary RCC: Additional tumor-level features

Papillary RCC has papillary, tubular, or solid architecture.

Larger tumors may be cystic and hemorrhagic.

Foamy histiocytes can populate papillary cores.

Psammoma bodies may occur.

These findings alone do not prove invasion in a tiny lesion.

Slide 43 · Clear cell RCC differs in lineage-pattern combination

Papillary adenoma

Clear cell RCC

Small cuboidal or polygonal bland cells

Papillary / tubulopapillary architecture

Generally scant cytoplasm

Commonly clear / granular cytoplasm

Nested, tubular, or solid arrangements

Prominent vascular network; VHL pathway

Slide 44 · Renal oncocytoma: A separate benign epithelial tumor

Papillary adenoma

Oncocytoma

Papillary / tubular architecture

Scant cytoplasm; Small nuclei

Typically a tiny cortical nodule

Eosinophilic granular cytoplasm

Many mitochondria; Distinct morphology

Often tan–mahogany, sometimes central scar

Slide 45 · Angiomyolipoma: Distinguish a mesenchymal tumor

Papillary adenoma

Angiomyolipoma

Epithelial tubules / papillae

Low-grade epithelial cells

Trisomy 7/17 may be present

Blood vessels + smooth muscle + adipose

Often associated with tuberous sclerosis

Bleeding is an important clinical issue

Slide 46 · Metanephric adenoma: A small-cell mimic

Papillary adenoma

Metanephric adenoma

Papillary or tubulopapillary

Low-grade cuboidal epithelium

CK7/AMACR often supportive

Closely packed tiny tubules; Glomeruloid areas

Very scant cytoplasm / basophilic look

Distinct ancillary profile may help

Slide 47 · Tubulopapillary hyperplasia may resemble a tiny tumor

Papillary adenoma

Tubulopapillary hyperplasia

Expansile, discrete neoplastic nodule

Distorts/displaces renal microarchitecture

Organized papillary and tubular proliferation

Non-expansile proliferation

Native renal architecture remains recognizable

Interpret in background kidney context

Slide 48 · Diagnostic comparison across four entities

Entity

Architecture / cytology

Crucial distinction

Papillary adenoma

Small bland papillary/tubular

≤15 mm + bland + appropriate sampling

Papillary RCC

Papillary/tubular, variable grade

Size >15 mm or malignant features

Oncocytoma

Eosinophilic oncocytes

Granular cytoplasm / solid architecture

Angiomyolipoma

Vessels + muscle + fat

Mesenchymal components

Slide 49 · Anatomic and histologic context must agree

Anatomic site

Architecture + cytology

Ancillary data

Classification

Do not shortcut

A papillary growth pattern cannot replace examination of the cells and background kidney.

Slide 50 · Background renal disease can alter detection

Papillary adenomas are encountered in kidneys examined for other diseases.

The published literature reports increased detection in end-stage kidneys.

Background tubular changes may complicate interpretation of microscopic foci.

Do not equate an association with proof that one lesion will progress.

Slide 51 · Multiplicity requires assessment, not assumption

Small papillary lesions

Related carcinoma context

Multiple papillary adenomas can be detected in parenchyma.

Record number and size where clinically relevant.

Review background disease and tumor history.

Papillary RCC also may be multifocal.

Multiplicity alone cannot establish an adenoma diagnosis.

Consider hereditary context only when the overall findings warrant it.

Slide 52 · Reporting example: Complete small benign lesion

Sample educational wording

Papillary adenoma of the kidney, 8 mm, low-grade papillary and tubular architecture, completely examined.

Why this works

Diagnosis is supported by the size, bland morphology, and adequate assessment of the full lesion.

Educational example

Not a universal reporting template or substitute for local synoptic requirements.

Slide 53 · Reporting example: Limited papillary tumor biopsy

Sample educational wording

Low-grade papillary renal epithelial neoplasm; Adenoma versus papillary RCC cannot be resolved on this limited sample.

Why this works

It communicates the observed morphology without inventing tumor dimensions or biologic classification.

Follow-up needed

Correlate with radiologic tumor size and clinical context.

Slide 54 · Case A: Incidental cortical nodule

Illustrative case

During nephrectomy for an unrelated process, an 8-mm cortical nodule is entirely sampled. Bland papillary / tubular epithelium is present.

Decision point

Which diagnosis best matches the findings?

Interpretation

Papillary adenoma is compatible with this complete, low-grade, sub-15-mm lesion.

Slide 55 · Case B: Low-grade but larger tumor

Illustrative case

A 22-mm renal cortical mass shows predominantly papillary growth, scant cytoplasm, and uniform low-grade nuclei.

Decision point

Does bland cytology justify the term adenoma?

Interpretation

No. The lesion exceeds the size convention and should be assessed/classified as papillary RCC.

Slide 56 · Case C: Small lesion with an alarming focus

Illustrative case

A 10-mm papillary lesion has areas with pronounced nuclear pleomorphism and conspicuous nucleoli.

Decision point

Can the size cutoff alone establish papillary adenoma?

Interpretation

No. Significant atypia precludes simply applying the benign size-based definition.

Slide 57 · Case D: Limited biopsy, uncertain total dimension

Illustrative case

A core biopsy shows bland CK7-positive / AMACR-positive papillary epithelial fragments. Tumor size is not established.

Decision point

What is a defensible pathology interpretation?

Interpretation

Describe a low-grade papillary renal epithelial neoplasm, acknowledge uncertainty, and correlate with imaging.

Slide 58 · Five diagnostic rules to retain

Papillary adenoma is a small, bland epithelial tumor of renal tubular type.

Papillary, tubular, and focal solid patterns may coexist.

Its low-grade appearance overlaps with papillary RCC.

A 15-mm boundary is used only in the correct morphologic setting.

Ancillary markers and genetics support lineage—not benign behavior.

Slide 59 · Primary source and supporting literature

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Chapter 20, pp. 862–864.

WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. 5th ed. IARC; 2022.

Khani F, Robinson BD. Precursor lesions of urologic malignancies. Arch Pathol Lab Med. 2017.

Renshaw AA et al. Diagnostic terminology for benign / low-risk tumors on renal cytology. Cancer Cytopathol. 2024.

Lobo J et al. WHO 2022 landscape of papillary and chromophobe RCC. Histopathology. 2022.